Conflicting Roles for p63 in Skin Development and Carcinogenesis (original) (raw)

E6/E7 and E6* From HPV16 and HPV18 Upregulate IL-6 Expression Independently of p53 in Keratinocytes

Luis F Jave-Suarez

Frontiers in Immunology, 2019

View PDFchevron_right

PRAME Updated: Diagnostic, Prognostic, and Therapeutic Role in Skin Cancer

Anna Bolzon

International journal of molecular sciences, 2024

View PDFchevron_right

P63: A Crucial Player in Epithelial Stemness Regulation

Yufang Shi

Oncogene, 2023

View PDFchevron_right

p62 Functions as a p38 MAP Kinase Regulator

Hiroyuki Osada

Biochemical and Biophysical Research Communications, 2000

View PDFchevron_right

p63 and p73, members of the p53 gene family, transactivate PKCδ

alessandro terrinoni

Biochemical Pharmacology, 2006

View PDFchevron_right

Identification of New p63 Targets in Human Keratinocytes

Carlotta Castagnoli

Cell Cycle, 2006

View PDFchevron_right

TP63 mutations are frequent in cutaneous melanoma, support UV etiology, but their role in melanomagenesis is unclear

Giorgia Foggetti

Oncology Reports, 2017

View PDFchevron_right

Transcriptional control orchestrated by p63 in skin disease

Marco Ferniani

2020

View PDFchevron_right

Expression of p16 protein in breast cancer

Jaudah Al-maghrabi

Polish Journal of Pathology, 2024

View PDFchevron_right

Molecular genetic changes during tumour progression in mouse skin

Rod Bremner

1990

View PDFchevron_right

P63 in Epithelial Development

Rita Cipollone

Cellular and Molecular Life Sciences, 2008

View PDFchevron_right

EXPRESSION OF p53 IN HUMAN BREAST CANCER

Veaceslav Fulga

Biological Markers in Fundamental and Clinical Medicine (collection of abstracts), 2017

View PDFchevron_right

Decreased expression of p63 in oral lichen planus and graft-vs.-host disease associated with oral inflammation

Majid Ebrahimi

Journal of Oral Pathology and Medicine, 2006

View PDFchevron_right

Genes and signaling pathways affecting the pathogenesis of melanoma

Bridget Varughese

Postdoc Journal, 2013

View PDFchevron_right

Identification of new genes associated with melanoma

Thomas Stempfl

Experimental Dermatology, 2011

View PDFchevron_right

P63 expression in papillary cystadenoma and mucoepidermoid carcinoma of minor salivary glands

Bruno Andrade

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2013

View PDFchevron_right

Role of p63 in Differentiating Morphologically Ambiguous Lesions of Prostate

Muhammad Zaheer Baig

2012

View PDFchevron_right

P63 Regulates Glutaminase 2 Expression

alessandro terrinoni

Cell Cycle, 2013

View PDFchevron_right

Divergence between the high rate of p53 mutations in skin carcinomas and the low prevalence of anti-p53 antibodies

N. Soufir

British Journal of Cancer, 2001

View PDFchevron_right

Transcriptional repression in normal human keratinocytes by wild-type and mutant p53

Efraín Garrido

Cancer Letters, 1995

View PDFchevron_right

p63, a p53 Homolog at 3q27–29, Encodes Multiple Products with Transactivating, Death-Inducing, and Dominant-Negative Activities

Daniel Caput

Molecular Cell, 1998

View PDFchevron_right

P53 is Essential for Chemotherapy-Induced Hair Loss

Andrei Gudkov

2000

View PDFchevron_right

P53: A Molecular Marker for the Detection of Cancer

Nikolina Vlatkovic

Expert Opinion on Medical Diagnostics, 2008

View PDFchevron_right

New p63 targets in keratinocytes identified by a genome-wide approach

Carlotta Castagnoli

The EMBO Journal, 2006

View PDFchevron_right

Association of p63 with Proliferative Potential in Normal and Neoplastic Human Keratinocytes

Frank McKeon

Journal of Investigative Dermatology, 1999

View PDFchevron_right